Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes

EU orphan designation number: EU/3/11/856   
Active ingredient: Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes
Indication: Treatment of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) due to thymidine phosphorylase deficiency
Sponsor: St George's University of London
Joint Research Office, Cranmer Terrace, London SW17 0RE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Centralised Orphan - Designation EMA/OD/136/10 (2011)2843 of 15/04/2011